Ajanta Pharma Ltd. Hits All-Time High, Rated 'Buy' by MarketsMOJO
Ajanta Pharma Ltd., a leading pharmaceutical company, has reached an all-time high in its stock price on August 8th, 2024. According to MarketsMojo, the stock is currently rated as a 'Buy' and is trading above its moving averages. It has also outperformed the Sensex, showcasing its strong growth and potential for investors.
Ajanta Pharma Ltd., a leading pharmaceutical company in the largecap industry, has recently reached an all-time high in its stock price. On August 8th, 2024, the company's stock price hit a record high, showcasing its strong performance and growth in the market.
According to MarketsMOJO, a leading stock analysis and recommendation platform, Ajanta Pharma's stock is currently rated as a 'Buy'. This further solidifies the company's positive outlook and potential for future growth.
In terms of price performance, Ajanta Pharma's stock is currently 1.25% away from its 52-week high of Rs 2966.6. While it may have underperformed the sector by -0.66% today, the stock has been consistently trading at a high price of 2929.95 since its opening.
Moreover, Ajanta Pharma's stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong and stable trend in the market.
In comparison to the Sensex, Ajanta Pharma has shown an impressive 1-year performance of 69.94%, while the Sensex has only grown by 20.36%. This showcases the company's strong growth and potential for investors.
With its consistent performance and positive outlook, Ajanta Pharma Ltd. is definitely a company to watch out for in the largecap pharma industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
